TDRD9

TDRD9 is a germline-expressed ATPase that functions in the nuclear piRNA pathway to silence retrotransposons and safeguard male fertility (PMID:20059948, PMID:28633017). In fetal mouse prospermatogonia it forms a complex with MIWI2 and co-localizes with it in piP-body cytoplasmic granules, where the MIWI2–TDRD9 module is required for LINE-1 retrotransposon silencing and de novo DNA methylation at LINE-1 loci; its assembly into piP-bodies depends on MAEL and is regulated upstream by MILI and TDRD1 (PMID:20059948, PMID:20011505). Active-site dissection established that TDRD9 ATPase activity is dispensable for piRNA biogenesis but essential for transposon silencing and male fertility, placing it at a silencing step downstream of or parallel to piRNA production (PMID:28633017). The protein operates in a TDRD pathway distinct from and non-redundant with TDRD7 (PMID:21670278), and also localizes with MILI and MVH to nuage-like structures in oocytes where retrotransposons are silenced (PMID:23924633). Homozygous and compound-heterozygous loss-of-function variants in human TDRD9 cause non-obstructive azoospermia and oligozoospermia through spermatogenic arrest, establishing TDRD9 as a recessive cause of human male infertility (PMID:40645105, PMID:39174853, PMID:28536242). Beyond the germline, TDRD9 has context-specific somatic roles: it is aberrantly expressed in a subset of lung carcinomas via promoter hypomethylation, where it protects cells from replicative stress and DNA double-strand breaks (PMID:29515758), and in neutrophils it interacts with CD80 to activate p38 MAPK signaling and upregulate PD-L1, suppressing cuproptosis during bacterial pneumonia (PMID:41792170).

1. 2009 High

   Established TDRD9 as a physical and functional partner of MIWI2 required for retrotransposon control, answering where TDRD9 acts in the piRNA machinery and what its loss does to the genome.

   Evidence Knockout mouse genetics with male sterility phenotype, reciprocal Co-IP, immunofluorescence, piRNA sequencing, and DNA methylation analysis in fetal prospermatogonia

   PMID:20059948

   Open questions at the time

   • Did not resolve the enzymatic step TDRD9 catalyzes within silencing
   • Structural basis of the TDRD9–MIWI2 interaction not defined
2. 2009 High

   Defined the granule architecture in which TDRD9 operates, showing it occupies piP-bodies as part of a MIWI2–TDRD9–MAEL module whose integrity depends on MAEL.

   Evidence Immunofluorescence co-localization and Mael knockout genetic epistasis in mouse germ cells

   PMID:20011505

   Open questions at the time

   • How MAEL physically maintains piP-body integrity unresolved
   • Order of module assembly not established
3. 2011 Medium

   Showed that TDRD9-mediated silencing is one of multiple non-redundant TDRD pathways against retrotransposons, distinguishing it from the piRNA-independent TDRD7 route.

   Evidence Single and double knockout mouse genetics and epistasis analysis of retrotransposon silencing and piRNA biogenesis

   PMID:21670278

   Open questions at the time

   • TDRD9 role inferred by comparison rather than direct manipulation here
   • Molecular distinction between the pathways not biochemically defined
4. 2013 Medium

   Extended TDRD9 localization to the female germline, placing it with MILI and MVH at oocyte nuage and uncoupling retrotransposon activation from female fertility.

   Evidence Immunofluorescence in mouse ovaries and retrotransposon expression analysis in Mvh, Mili, and Gasz mutants

   PMID:23924633

   Open questions at the time

   • Functional requirement of TDRD9 in oocytes not directly tested
   • Whether TDRD9 ATPase activity matters in oocytes unknown
5. 2017 High

   Pinpointed the enzymatic requirement by showing TDRD9 ATPase activity is dispensable for piRNA biogenesis but essential for transposon silencing and male fertility, separating helicase function from RNA processing.

   Evidence ATPase-dead knock-in mice with piRNA sequencing, transposon expression, and fertility assays

   PMID:28633017

   Open questions at the time

   • The direct ATPase substrate/target of TDRD9 not identified
   • Mechanism linking ATPase activity to chromatin silencing unresolved
6. 2017 Medium

   Revealed an unexpected somatic role, showing TDRD9 is aberrantly expressed in lung cancer via hypomethylation and protects tumor cells from replicative stress.

   Evidence siRNA knockdown and overexpression with cell cycle analysis, γH2A.X/DNA-PKcs readouts, and aphidicolin sensitivity assays in NSCLC lines

   PMID:29515758

   Open questions at the time

   • Molecular mechanism of replicative-stress protection unknown
   • Whether ATPase activity is required in this context untested
   • Single-lab, cell-line based
7. 2019 Medium

   Refined the germline interaction map in rat gonocytes, showing TDRD9 co-localizes with MAEL and PIWIL4 but does not physically bind DAZL or MAEL.

   Evidence Immunofluorescence double-labeling and reciprocal co-IP in rat embryonic gonocytes

   PMID:31181099

   Open questions at the time

   • Direct binding partners of TDRD9 in gonocytes not identified
   • Reconciliation with mouse MAEL-dependent piP-body data not addressed
8. 2024 Medium

   Broadened the human disease spectrum, showing compound heterozygous TDRD9 mutations cause oligozoospermia, not only complete azoospermia.

   Evidence Whole-exome and Sanger sequencing with minigene splicing assay in a human patient

   PMID:39174853

   Open questions at the time

   • Single family
   • Genotype–phenotype severity relationship not systematically defined
9. 2025 Medium

   Confirmed TDRD9 as essential for human spermatogenesis, with loss-of-function variants causing non-obstructive azoospermia and meiotic defects.

   Evidence Whole-exome and Sanger sequencing, testicular histology, immunofluorescence, and small RNA sequencing in patients

   PMID:40645105

   Open questions at the time

   • Single family per variant
   • Whether human piRNA/transposon defects mirror mouse not fully resolved
10. 2026 Medium

    Identified a distinct innate-immune function, showing TDRD9 interacts with CD80 to activate p38 MAPK, upregulate PD-L1, and suppress neutrophil cuproptosis during bacterial pneumonia.

    Evidence siRNA knockdown and adoptive transfer of TDRD9-silenced neutrophils into mice with lung injury readout and pathway analysis

    PMID:41792170

    Open questions at the time

    • Direct nature of TDRD9–CD80 interaction not structurally defined
    • How a germline RNA helicase couples to p38 signaling mechanistically unknown
    • Single-lab

• The direct molecular substrate of TDRD9 ATPase activity and the mechanism by which its helicase activity drives transposon silencing and DNA methylation remain undefined.
• No substrate identified
• No structural model of TDRD9 or its complexes
• Link between germline silencing role and somatic CD80/p38 and replicative-stress functions unexplained